Letter to “High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?”

被引：0
|
作者：
Burcu Candemir
Şafak Akın
机构：
[1] University of Health Sciences,
[2] Gulhane Faculty of Medicine,undefined
[3] Department of Endocrinology and Metabolism,undefined
来源：
Endocrine | 2021年 / 71卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：262 / 262
相关论文
共 50 条
  • [1] Letter to "High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?"
    Candemir, Burcu
    Akin, Safak
    ENDOCRINE, 2021, 71 (01) : 262 - 262
  • [2] High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?
    Espinosa-Cardenas, Etual
    Sanchez-Garcia, Miriam
    Ramirez-Renteria, Claudia
    Mendoza-Zubieta, Victoria
    Sosa-Eroza, Ernesto
    Mercado, Moises
    ENDOCRINE, 2020, 70 (01) : 143 - 149
  • [3] High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?
    Etual Espinosa-Cárdenas
    Miriam Sánchez-García
    Claudia Ramírez-Rentería
    Victoria Mendoza-Zubieta
    Ernesto Sosa-Eroza
    Moises Mercado
    Endocrine, 2020, 70 : 143 - 149
  • [4] Response to Letter to the Editor: “High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?”
    Etual Espinosa-Cárdenas
    Miriam Sánchez-García
    Claudia Ramírez-Rentería
    Victoria Mendoza-Zubieta
    Ernesto Sosa-Eroza
    Moises Mercado
    Endocrine, 2021, 71 : 263 - 264
  • [5] Response to Letter to the Editor: "High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: is it necessary to restart treatment?"
    Espinosa-Cardenas, Etual
    Sanchez-Garcia, Miriam
    Ramirez-Renteria, Claudia
    Mendoza-Zubieta, Victoria
    Sosa-Eroza, Ernesto
    Mercado, Moises
    ENDOCRINE, 2021, 71 (01) : 263 - 264
  • [6] Recurrence and restart of sirolimus in vascular anomalies after withdrawal
    Liu, Hongyuan
    Yang, Xi
    Jia, Hechen
    Hu, Li
    Xu, Zian
    Chen, Hui
    Lin, Xiaoxi
    JOURNAL OF DERMATOLOGY, 2023, 50 (04): : E119 - E120
  • [7] Recurrence of Hyperprolactinemia after Withdrawal of Long-Term Cabergoline Therapy
    Kharlip, J.
    Salvatori, R.
    Yenokyan, G.
    Wand, G. S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (07): : 2428 - 2436
  • [8] Prospective Study of High-Dose Cabergoline Treatment of Prolactinomas in 150 Patients
    Ono, Masami
    Miki, Nobuhiro
    Kawamata, Takakazu
    Makino, Rena
    Amano, Kosaku
    Seki, Toshiro
    Kubo, Osami
    Hori, Tomokatsu
    Takano, Kazue
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (12): : 4721 - 4727
  • [9] Recurrence of Hyperprolactinemia After Withdrawal of Long-Term Cabergoline Therapy COMMENT
    Kharlip, J.
    Salvatori, R.
    Yenokyan, G.
    Wand, G. S.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2010, 65 (01) : 28 - 29
  • [10] EVOLUTION OF PROLACTINOMAS UNDER AND AFTER WITHDRAWAL OF MEDICAL-TREATMENT
    LINQUETTE, M
    FOSSATI, P
    MAZZUCA, M
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1985, 169 (08): : 1145 - 1149
12345